Clinical Trial

Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working

Study acronym: prospective
Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if topical amphotericin b solution works to treat resistant cases of tinea capitis in children. It will also learn about the safety of drug. The main questions it aims to answer are: Does amphotericin b solution effective in cases not cured by systemic antifungal tab? Participants will: use topical amphotericin b solution every day for8 weeks Visit the clinic once every 1 week for follow up then follow up after 1 month and fungal culture will be done to test if the treatment working
Trial Details
NCT Number NCT06980493
Lead Sponsor Sohag University
Conditions Tinea Capitis
Enrollment 30 participants
Start Date 2025-04-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-20